G1 Therapeutics EBITDA 2016-2024 | GTHX
G1 Therapeutics ebitda from 2016 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| G1 Therapeutics Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-38 |
| 2022 | $-133 |
| 2021 | $-141 |
| 2020 | $-95 |
| 2019 | $-129 |
| 2018 | $-89 |
| 2017 | $-61 |
| 2016 | $-30 |
| 2015 | $-15 |
| G1 Therapeutics Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-4 |
| 2024-03-31 | $-9 |
| 2023-12-31 | $-8 |
| 2023-09-30 | $-15 |
| 2023-06-30 | $11 |
| 2023-03-31 | $-25 |
| 2022-12-31 | $-30 |
| 2022-09-30 | $-21 |
| 2022-06-30 | $-36 |
| 2022-03-31 | $-46 |
| 2021-12-31 | $-37 |
| 2021-09-30 | $-41 |
| 2021-06-30 | $-38 |
| 2021-03-31 | $-25 |
| 2020-12-31 | $-24 |
| 2020-09-30 | $-9 |
| 2020-06-30 | $-31 |
| 2020-03-31 | $-32 |
| 2019-12-31 | $-36 |
| 2019-09-30 | $-34 |
| 2019-06-30 | $-33 |
| 2019-03-31 | $-26 |
| 2018-12-31 | $-26 |
| 2018-09-30 | $-21 |
| 2018-06-30 | $-22 |
| 2018-03-31 | $-21 |
| 2017-12-31 | $-17 |
| 2017-09-30 | $-16 |
| 2017-06-30 | $-15 |
| 2017-03-31 | $-12 |
| 2016-12-31 | |
| 2016-09-30 | $-7 |
| 2016-06-30 | $-7 |
| 2015-12-31 | |
